M. Tessema

发表

Ulrich Lehmann, M. Tessema, U. Lehmann, 2004, Virchows Archiv.

Vesicular trafficking of tyrosine kinase receptors and associated proteins in the regulation of signaling and vascular function.

A. Wandinger-Ness, M. Tessema, Sanchita Mukherjee, 2006, Circulation research.

Aberrant expression of insulin-like growth factor-2 (IGF-2) in Philadelphia chromosome negative chronic myeloproliferative disorders.

M. Tessema, H. Kreipe, R. von Wasielewski, 2004, Leukemia research.

Functional Identification of Cancer-Specific Methylation of CDO1, HOXA9, and TAC1 for the Diagnosis of Lung Cancer

J. Herman, K. Schuebel, S. Baylin, 2014, Clinical Cancer Research.

Vasorin/ATIA Promotes Cigarette Smoke–Induced Transformation of Human Bronchial Epithelial Cells by Suppressing Autophagy-Mediated Apoptosis

S. Leng, S. Belinsky, Zheng‐gang Liu, 2019, Translational oncology.

Muc1 knockout potentiates murine lung carcinogenesis involving an epiregulin-mediated EGFR activation feedback loop

S. Leng, S. Belinsky, M. Tessema, 2017, Carcinogenesis.

Epigenetic Repression of CCDC37 and MAP1B Links Chronic Obstructive Pulmonary Disease to Lung Cancer

J. Siegfried, J. Weissfeld, S. Belinsky, 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Glutathione‐S‐transferase‐green fluorescent protein fusion protein reveals slow dissociation from high site density beads and measures free GSH

D. Cimino, A. Waller, L. Sklar, 2006, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

Concomitant promoter methylation of multiple genes in lung adenocarcinomas from current, former and never smokers.

K. Schuebel, S. Baylin, S. Belinsky, 2009, Carcinogenesis.

Identification of novel epigenetic abnormalities as sputum biomarkers for lung cancer risk among smokers and COPD patients.

S. Belinsky, S. Randell, Y. Tesfaigzi, 2020, Lung cancer.

5-Azacytidine inhaled dry powder formulation profoundly improves pharmacokinetics and efficacy for lung cancer therapy through genome reprogramming

S. Belinsky, M. Tessema, T. March, 2020, British Journal of Cancer.

Common cancer-driver mutations and their association with abnormally methylated genes in lung adenocarcinoma from never-smokers.

S. Ramalingam, S. Belinsky, M. Tessema, 2018, Lung cancer.

Differential Epigenetic Regulation of TOX Subfamily High Mobility Group Box Genes in Lung and Breast Cancers

N. Joste, S. Leng, S. Belinsky, 2012, PloS one.

ANK1 Methylation regulates expression of MicroRNA-486-5p and discriminates lung tumors by histology and smoking status.

A. Spira, S. Belinsky, T. Ryba, 2017, Cancer letters.

Mining the epigenome for methylated genes in lung cancer.

S. Belinsky, M. Tessema, 2008, Proceedings of the American Thoracic Society.

Promoter methylation of genes in and around the candidate lung cancer susceptibility locus 6q23-25.

S. Baylin, M. Brock, L. van Neste, 2008, Cancer research.

Genome-wide unmasking of epigenetically silenced genes in lung adenocarcinoma from smokers and never smokers.

L. van Neste, S. Belinsky, M. Tessema, 2014, Carcinogenesis.

Gene Expression Studies Demonstrate that the K-ras/Erk MAP Kinase Signal Transduction Pathway and Other Novel Pathways Contribute to the Pathogenesis of Cumene-induced Lung Tumors

J. Parker, S. Belinsky, J. Collins, 2008, Toxicologic pathology.

SULF2 Methylation is Prognostic for Lung Cancer Survival and Increases Sensitivity to Topoisomerase-I inhibitors via Induction of ISG15

J. Siegfried, S. Dacic, S. Belinsky, 2011, Oncogene.

Nephroblastomatosis and loss of WT1 expression associated with trisomy 13

M. Tessema, H. Kreipe, L. Wilkens, 2006, Virchows Archiv.

The A/G Allele of Rs16906252 Predicts for MGMT Methylation and Is Selectively Silenced in Premalignant Lesions from Smokers and in Lung Adenocarcinomas

M. Prados, F. Gilliland, J. Costello, 2011, Clinical Cancer Research.

Inhibition of the hexosamine biosynthesis pathway potentiates cisplatin cytotoxicity by decreasing BiP expression in non–small‐cell lung cancer cells

S. Leng, S. Belinsky, M. Tessema, 2019, Molecular carcinogenesis.

EMT and stem cell-like properties associated with miR-205 and miR-200 epigenetic silencing are early manifestations during carcinogen-induced transformation of human lung epithelial cells.

S. Leng, S. Belinsky, Daniel E. Juri, 2011, Cancer research.

GATA2 is Epigenetically Repressed in Human and Mouse Lung Tumors and Is Not Requisite for Survival of KRAS Mutant Lung Cancer

S. Leng, S. Belinsky, Daniel E. Juri, 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

GATA 2 Knockdown and Cell Death Assays Cells

S. Leng, S. Belinsky, Daniel E. Juri, 2022 .

Predictive Biomarkers and Personalized Medicine The A / G Allele of Rs 16906252 Predicts for MGMT Methylation and Is Selectively Silenced in Premalignant Lesions from Smokers and in Lung Adenocarcinomas

M. Prados, F. Gilliland, J. Costello, 2011 .

Methylation of CDO 1 , HOXA 9 , and TAC 1 for the Diagnosis of Lung Cancer

J. Herman, L. V. Neste, K. Schuebel, 2014 .

Re-expression of CXCL14, a common target for epigenetic silencing in lung cancer, induces tumor necrosis

L. van Neste, S. Belinsky, M. Tessema, 2010, Oncogene.

Aerosolised 5-azacytidine suppresses tumour growth and reprogrammes the epigenome in an orthotopic lung cancer model

M. D. Reed, S. Belinsky, M. Tessema, 2013, British Journal of Cancer.

Inhibition of GFAT1 in lung cancer cells destabilizes PD-L1 protein.

S. Belinsky, M. Tessema, Wenshu Chen, 2021, Carcinogenesis.